Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Glycopyre 0.2mg Injection 1ml
Manufacturer/Marketed By : SALS LTD
$0.13 $0.12
Glycopyre 0.2mg/1ml injection contains an active component as Glycopyrrolate. It belongs to a class of drugs known as anticholinergics. It is primarily used to reduce excessive saliva and secretions in...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
GLYCOPYRROLATE
Active Pharmaceutical Ingredient
Glycopyre 0.2mg Injection 1ml
$0.13
$0.12
Glycopyre 0.2mg/1ml injection contains an active component as Glycopyrrolate. It belongs to a class of drugs known as anticholinergics. It is primarily used to reduce excessive saliva and secretions in the airways during surgical procedures or to manage conditions such as drooling, chronic obstructive pulmonary disease (COPD), and peptic ulcers. Additionally, Glycopyre 0.2mg/1ml injection may be used in combination with other medications to alleviate symptoms of irritable bowel syndrome (IBS) and gastrointestinal hypermotility. However, it is essential to use this medication under medical supervision due to potential side effects and drug interactions. Individuals with known hypersensitivity or allergy to Glycopyre 0.2mg/1ml injection or any of its components should avoid its use. It may increase intraocular pressure, so it is contraindicated in patients with narrow-angle glaucoma. The use of this medication is contraindicated in individuals with severe ulcerative colitis due to the risk of toxic megacolon. Dose adjustments may be required in individuals with hepatic or renal impairment, as the clearance of this medication may be reduced. It may cause constipation or intestinal obstruction, making it important to use with caution in individuals with gastrointestinal disorders.
Active Pharmaceutical Ingredient
Uses
• Blockage of secretion and reflexes before anesthesia.
• Management of peptic ulcer
• Alleviation of catheter-related bladder discomfort after surgery
Benefits
Glycopyre 0.2mg/1ml injection works by inhibiting the action of acetylcholine present in the nerves and smooth muscles. It protects the heart from getting excessively stimulated and also reduces secretions from the pharynx, bronchi, and trachea during anesthesia. It counteracts the undesirable effects caused by muscle relaxants.
Side Effects
Glycopyre 0.2mg/1ml injection cause some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Dry mouth
• Blurred vision
• Dizziness
• Constipation
• Difficulty urinating
• Increased heart rate
• Headache
• Nausea
Common Side Effects
• Allergic reactions (rash, itching, swelling, severe dizziness, difficulty breathing)
• Severe abdominal pain or bloating
• Rapid or irregular heartbeat
• Trouble swallowing or speaking
• Severe drowsiness or confusion
• Mental or mood changes (hallucinations, agitation, delirium)
• Severe constipation or bowel obstruction
• Urinary retention (inability to urinate)
How To Use
Glycopyre 0.2mg/1ml injection is typically available in oral tablet or injectable form. The dosage and administration instructions may vary depending on the specific condition being treated and individual factors. It is important to follow the instructions provided by the healthcare professional or the medication's label. Generally, the tablets are taken orally with or without food, as directed by the doctor.
Safety Advice
• Breast Feeding: The safety of Glycopyre 0.2mg/1ml injection during breastfeeding has not been well studied, and limited information is available regarding its excretion into breast milk. As a result, it is recommended to exercise caution when using it while breastfeeding.
• Alcohol: Consuming alcohol while taking Glycopyre 0.2mg/1ml injection is generally not recommended. It has central nervous system (CNS) depressant effects, as it can cross the blood-brain barrier and potentially cause drowsiness or dizziness.
• Liver: Glycopyre 0.2mg/1ml injection should be used with caution in individuals with liver impairment or hepatic dysfunction. The metabolism and clearance of medications, including this medication, can be altered in patients with liver problems.
• Lungs: Glycopyre 0.2mg/1ml injection can be used safely in lung conditions such as chronic obstructive pulmonary disease (COPD) and other respiratory conditions where excessive secretions are a concern. It is important to consult with a healthcare professional who can evaluate the specific lung condition and provide personalized advice on the safe and appropriate use of this medication in each individual case.
• Driving: Glycopyre 0.2mg/1ml injection can cause certain side effects that may impair your ability to drive safely. These side effects can include dizziness, lightheadedness, blurred vision, and transient changes in heart rhythm. These effects can interfere with your concentration, alertness, and coordination, making driving potentially unsafe.
• Pregnancy: The safety of Glycopyre 0.2mg/1ml injection during pregnancy has not been extensively studied, and limited information is available regarding its use in pregnant women. Therefore, the use of it during pregnancy should be carefully considered and evaluated by a healthcare professional, weighing the potential benefits against the potential risks.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.